[Diagnostic significance of antibody detection to various hepatitis C virus antigens in patients with acute and chronic HCV-infection]. 2002

N D Iushchuk, and O L Ogienko, and I V Kruglov, and O O Znoĭko, and D M Braginskiĭ, and Iu A Semiletov, and M P Finogenova, and T I Alekseenkova, and M V Ianina, and V A Shibnev, and N V Doroshenko

OBJECTIVE To examine diagnostic value of antibodies to various HCV antigens in patients with acute and chronic HCV-infection. METHODS Enzyme immunoassay has tested blood sera from 136 patients with icteric acute hepatitis C (AHC) and 45 patients with chronic HCV infection for IgG antibodies to antigens of proteins core, NS4, NS5, HCV. Synthetic peptides core-16, NS4-20, NS5-23 were used as antigens. RESULTS Patients with icteric AHC had IgG antibodies to antigens of both structural protein core and non-structural proteins NS4, NS5 of HCV as early as the first 10 days of jaundice. Occurrence of anti-core and anti-NS4 increases with the disease duration. Incidence of anti-NS4 correlated with duration of previous intravenous drug addiction. In patients with AHC early in the icteric period anti-core, anti-NS4, anti-NS5 were present less frequently than in patients with chronic HCV infection having elevated levels of AlAT. Significant differences were found neither with the group with normal AlAt nor in the spectrum of the detected antibodies between patients with acute and chronic HCV infection. CONCLUSIONS Despite different frequency of anti-core, anti-NS4, anti-NS5 detection in patients with icteric AHC and patients with chronic HCV-infection and high AlAT, their high incidence rate in this or that group and absence of differences by the spectrum of the studied antibodies do not allow the fact of their detection to be a diagnostic marker differentiating acute HCV-infection with chronic one.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011237 Predictive Value of Tests In screening and diagnostic tests, the probability that a person with a positive test is a true positive (i.e., has the disease), is referred to as the predictive value of a positive test; whereas, the predictive value of a negative test is the probability that the person with a negative test does not have the disease. Predictive value is related to the sensitivity and specificity of the test. Negative Predictive Value,Positive Predictive Value,Predictive Value Of Test,Predictive Values Of Tests,Negative Predictive Values,Positive Predictive Values,Predictive Value, Negative,Predictive Value, Positive
D002908 Chronic Disease Diseases which have one or more of the following characteristics: they are permanent, leave residual disability, are caused by nonreversible pathological alteration, require special training of the patient for rehabilitation, or may be expected to require a long period of supervision, observation, or care (Dictionary of Health Services Management, 2d ed). For epidemiological studies chronic disease often includes HEART DISEASES; STROKE; CANCER; and diabetes (DIABETES MELLITUS, TYPE 2). Chronic Condition,Chronic Illness,Chronically Ill,Chronic Conditions,Chronic Diseases,Chronic Illnesses,Condition, Chronic,Disease, Chronic,Illness, Chronic
D003937 Diagnosis, Differential Determination of which one of two or more diseases or conditions a patient is suffering from by systematically comparing and contrasting results of diagnostic measures. Diagnoses, Differential,Differential Diagnoses,Differential Diagnosis
D005260 Female Females
D006526 Hepatitis C INFLAMMATION of the LIVER in humans caused by HEPATITIS C VIRUS, a single-stranded RNA virus. Its incubation period is 30-90 days. Hepatitis C is transmitted primarily by contaminated blood parenterally and is often associated with transfusion and intravenous drug abuse. However, in a significant number of cases, the source of hepatitis C infection is unknown. Hepatitis, Viral, Non-A, Non-B, Parenterally-Transmitted,Parenterally-Transmitted Non-A, Non-B Hepatitis,PT-NANBH,Parenterally Transmitted Non A, Non B Hepatitis
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000208 Acute Disease Disease having a short and relatively severe course. Acute Diseases,Disease, Acute,Diseases, Acute
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

N D Iushchuk, and O L Ogienko, and I V Kruglov, and O O Znoĭko, and D M Braginskiĭ, and Iu A Semiletov, and M P Finogenova, and T I Alekseenkova, and M V Ianina, and V A Shibnev, and N V Doroshenko
May 2023, The Korean journal of internal medicine,
N D Iushchuk, and O L Ogienko, and I V Kruglov, and O O Znoĭko, and D M Braginskiĭ, and Iu A Semiletov, and M P Finogenova, and T I Alekseenkova, and M V Ianina, and V A Shibnev, and N V Doroshenko
April 1998, Gut,
N D Iushchuk, and O L Ogienko, and I V Kruglov, and O O Znoĭko, and D M Braginskiĭ, and Iu A Semiletov, and M P Finogenova, and T I Alekseenkova, and M V Ianina, and V A Shibnev, and N V Doroshenko
September 2015, Klinicka mikrobiologie a infekcni lekarstvi,
N D Iushchuk, and O L Ogienko, and I V Kruglov, and O O Znoĭko, and D M Braginskiĭ, and Iu A Semiletov, and M P Finogenova, and T I Alekseenkova, and M V Ianina, and V A Shibnev, and N V Doroshenko
June 1992, Hepatology (Baltimore, Md.),
N D Iushchuk, and O L Ogienko, and I V Kruglov, and O O Znoĭko, and D M Braginskiĭ, and Iu A Semiletov, and M P Finogenova, and T I Alekseenkova, and M V Ianina, and V A Shibnev, and N V Doroshenko
September 2008, Journal of medical virology,
N D Iushchuk, and O L Ogienko, and I V Kruglov, and O O Znoĭko, and D M Braginskiĭ, and Iu A Semiletov, and M P Finogenova, and T I Alekseenkova, and M V Ianina, and V A Shibnev, and N V Doroshenko
November 1995, Journal of hepatology,
N D Iushchuk, and O L Ogienko, and I V Kruglov, and O O Znoĭko, and D M Braginskiĭ, and Iu A Semiletov, and M P Finogenova, and T I Alekseenkova, and M V Ianina, and V A Shibnev, and N V Doroshenko
March 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America,
N D Iushchuk, and O L Ogienko, and I V Kruglov, and O O Znoĭko, and D M Braginskiĭ, and Iu A Semiletov, and M P Finogenova, and T I Alekseenkova, and M V Ianina, and V A Shibnev, and N V Doroshenko
January 2008, Casopis lekaru ceskych,
N D Iushchuk, and O L Ogienko, and I V Kruglov, and O O Znoĭko, and D M Braginskiĭ, and Iu A Semiletov, and M P Finogenova, and T I Alekseenkova, and M V Ianina, and V A Shibnev, and N V Doroshenko
July 1997, The Journal of infectious diseases,
N D Iushchuk, and O L Ogienko, and I V Kruglov, and O O Znoĭko, and D M Braginskiĭ, and Iu A Semiletov, and M P Finogenova, and T I Alekseenkova, and M V Ianina, and V A Shibnev, and N V Doroshenko
May 1993, Journal of clinical microbiology,
Copied contents to your clipboard!